What are the opening hours?

Monday 8am - 4pm Tuesday 8am - 4pm Wednesday 8am - 4pm Thursday 8am - 4pm Friday 8am - 4pm

Advanced Molecular Imaging & Therapy

Home
United States
Glen Burnie, MD
Advanced Molecular Imaging & Therapy

Theranostics Center of Excellence

10/01/2023

Happy Nuclear Medicine Week! The hottest profession in healthcare!

04/02/2023

Pluvicto is currently only manufactured at a facility in Italy, the company said.

04/02/2023

celebrates World Theranostics Day 2023 in honor of Dr. Saul Hertz! Get the latest radiopharmaceutical therapy updates from SNMMI and around the world at the SNMMI Radiopharmaceutical Therapy Central: therapy.snmmi.org

03/09/2023

https://amit.informz.net/informzdataservice/onlineversion/ind/bWFpbGluZ2luc3RhbmNlaWQ9ODk0MDMyMCZzdWJzY3JpYmVyaWQ9NzY3NTQ5NjE2

A supply problem with Pluvicto [177Lu-vipivotide tetraxetan; Novartis], the radiopharmaceutical used to treat metastatic prostate cancer, has led to shortages resulting in a delay of 3 months or longer for new patients, which is having a profound negative impact on patient care.1,2

11/08/2022

10/26/2021

06/27/2021

One of the many therapies we offer at our facility

https://www.lutathera.com/

Your guide to gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and treatment with LUTATHERA® (lutetium Lu 177 dotatate). This website has been developed to help you learn more about GEP-NETs and treatment with LUTATHERA. Check back often, as the information in this website will be updated as...

09/19/2020

AMIT is committed to leadership and excellence. As of today, Dr. Michael Morris joins the leadership team of the Mid-Eastern Chapter of the Society of Nuclear Medicine and Molecular Imaging. Aaron Scott also serves as the current TS President of the chapter.

05/05/2020

Dr. Francis Collins gave us all a touching and artistic COVID-19 PSA https://t.co/NsVvwhtYaT

04/28/2020

https://youtu.be/4ucdpnLWoaI

A Neuroendocrine Tumor (NET) is an uncommon, poorly understood cancer type that is increasingly diagnosed. But oftentimes only after years have passed and th...

04/25/2020

If you suffer from metastatic prostate cancer affecting your bones and want to know if you might be a candidate for Xofigo (Ra-223-dichloride), call or email to schedule a consultation.

04/25/2020

We provide private treatment rooms in a comfortable, quiet outpatient setting designed to produce a calm and relaxing environment for our patients. Our office specializes specifically in Nuclear Medicine Therapy and is accessible to assure that your consultation and therapy days are convenient.

04/25/2020

If you suffer from metastatic or recurrent neuroendocrine (carcinoid) cancer and want to know if you may be a candidate for Peptide Receptor Radionuclide Therapy (PRRT) with Lutathera (Lu-177-DOTATATE), call or email to schedule a consultation.

04/25/2020

Advanced Molecular Imaging and Therapy (AMIT) is pleased to offer Maryland and the mid-atlantic region access to Nuclear Medicine Therapy at our AMIT Clinic facility in the Crane Health Park, 331 Oak Manor Drive, Suite 201, Glen Burnie, MD.

04/24/2020

03/17/2020

03/17/2020

Address

331 Oak Manor Drive, Suite 201
Glen Burnie, MD
21061

Opening Hours

Monday	8am - 4pm
Tuesday	8am - 4pm
Wednesday	8am - 4pm
Thursday	8am - 4pm
Friday	8am - 4pm

Telephone

+14433331894

Website

https://www.amitclinic.com/

Alerts

Be the first to know and let us send you an email when Advanced Molecular Imaging & Therapy posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Our Center: AMIT Clinic

Our practice was founded based on the mission to create a dedicated Theranostics Center for the patients of Maryland and the surrounding area. Theranostics is an emerging area of Nuclear Medicine that combines Therapy (Thera-) with Diagnostics (-ostics). First, a tiny amount of a molecule called a ‘radiotracer’ is administered that allows for the acquisition of a molecular imaging test, such as a positron emission tomography (PET) scan or a single photon emission computed tomography (SPECT) scan at a diagnostic imaging center. Then, the molecular imaging results, clinical notes, and pathology results are reviewed in a personalized consultation with the patient at our clinic. If the molecular imaging and other clinical information supports a potential benefit of molecular therapy, we have a discussion regarding the risks and benefits related to this therapy together with the patient as well as a discussion of the treatment process. Together with the patient, we determine whether therapy is a preferable option. At a molecular therapy visit, a similar molecule to the one used in the initial molecular imaging test is combined with a radioactive isotope, which delivers targeted radiopharmaceutical therapy (internal radiation therapy) for the purpose of causing cancerous cell death. Our AMIT Clinic is focused on delivering the highest quality of care with a particular emphasis on patient comfort.